BeStock  

Adaptive Biotechnologies ADPT

US equityMarket cap rank #2124Diagnostics & Research
$27.93 −$0.12 (-0.43%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $27.89 -0.14%
Open$27.43
Prev close$28.05
Day range$27.15 – $28.23
Volume2.48M
Market cap$4.52B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership102.6%+2.63 pts vs. prior quarter
Institutions holding391+18 vs. prior quarter
Insider trades (recent)0 buys / 50 sellsNet selling
ARK fund activity-108,120 sh1 recent transactions · last 8 Jul 2026
Short interest7.19% of floatDays to cover 6.1 · as of 30 Oct 2026
Short-sale volume share12.7%5-day average of daily volume

Short-sale volume as % of daily volume

6%11%17%22%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$4.41M (5 inflow days, 15 outflow days).

Net flow by order size, last 20 sessions

−$2.0MSuper−$2.5MBig+$791.8KMid+$10.0MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 38.8% of shares outstanding.

Largest holders

  • Viking Global Investors LP18.53%
  • BlackRock9.45%
  • Vanguard Capital Management, LLC3.98%
  • Wellington Management Group3.65%
  • Vanguard Portfolio Management, LLC3.24%
  • D. E. Shaw & Co., L.P.2.86%
  • T. Rowe Price Group, Inc.2.75%
  • Westfield Capital Management Company, L.P.2.64%

By investor type

  • Mutual Fund69.63%
  • Hedge Fund26.51%
  • Individual/Insider2.54%
  • Public Company2.49%
  • Private Company1.68%
  • Insurance Company0.88%
  • VC/PE Fund0.75%
  • Government Pension Fund0.36%

Reported short interest has fallen from 8.35% to 7.19% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Principal Global Investors, LLC Mutual Fund 2026/Q3 +2,406,860 1.5%
UBS Asset Management Mutual Fund 2026/Q3 +1,157,182 1.0%
Mackenzie Financial Corporation Mutual Fund 2026/Q3 +729,774 0.5%
BNY Mellon Asset Management Mutual Fund 2026/Q3 +593,996 0.6%
Renaissance Technologies Corp. Hedge Fund 2026/Q3 +564,300 0.5%
Franklin Resources Mutual Fund 2026/Q3 +530,097 0.4%
Capricorn Fund Managers Limited Hedge Fund 2026/Q3 +344,307 0.2%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +804,370 0.9%
D. E. Shaw & Co., L.P. Hedge Fund 2026/Q3 +2,660,249 2.9%
Wellington Management Group Mutual Fund 2026/Q3 +2,053,944 3.7%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +1,959,468 2.7%
BlackRock Mutual Fund 2026/Q3 +1,836,134 9.5%
Perceptive Advisors LLC VC/PE Fund 2026/Q3 +1,064,825 0.8%
Vanguard Portfolio Management, LLC Mutual Fund 2026/Q3 +984,757 3.4%
Teachers Insurance and Annuity Association-College Retirement Equities Fund Mutual Fund 2026/Q3 +960,857 1.4%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
12 Nov 2026 Julie Rubinstein President Derivative Exercise and Sale -35,228 $31.22 377,802
10 Nov 2026 Chad Robins Chairperson & CEO Intent to Sell (Form 144) -73,221 $29.94 –
10 Nov 2026 Susan Bobulsky Chief Commercial Officer of MRD Automatic Disposition -1,875 $32.00 387,475
9 Nov 2026 Julie Rubinstein President Derivative Exercise and Sale -23,762 $30.58 377,802
8 Nov 2026 Chad Robins Chairperson & CEO Other Disposition -100,000 – 1,420,498
5 Nov 2026 Julie Rubinstein President Derivative Exercise and Sale -35,643 $27.88 377,802
2 Nov 2026 Julie Rubinstein President Derivative Exercise and Sale -35,643 $27.45 377,802
28 Oct 2026 Julie Rubinstein President Derivative Exercise and Sale -35,643 $28.90 377,802
25 Oct 2026 Julie Rubinstein President Derivative Exercise and Sale -35,643 $26.30 377,802
20 Oct 2026 Julie Rubinstein President Derivative Exercise and Sale -35,643 $25.57 377,802
15 Oct 2026 Julie Rubinstein President Derivative Exercise and Sale -35,643 $25.82 377,802
12 Oct 2026 Julie Rubinstein President Derivative Exercise and Sale -35,643 $26.41 377,802
7 Oct 2026 Julie Rubinstein President Derivative Exercise and Sale -35,643 $30.53 377,802
5 Oct 2026 Susan Bobulsky Chief Commercial Officer of MRD Automatic Disposition -6,444 $30.00 389,350
4 Oct 2026 Julie Rubinstein President Derivative Exercise and Sale -35,643 $29.67 377,802
30 Sep 2026 Julie Rubinstein President Intent to Sell (Form 144) -379,777 $28.90 –
30 Sep 2026 Francis Lo Chief Human Resources Officer Derivative Exercise and Sale -26,792 $28.61 223,367
15 Sep 2026 Francis Lo Chief Human Resources Officer Automatic Disposition -9,846 $28.57 223,367
15 Sep 2026 Francis Lo Chief Human Resources Officer Derivative Exercise and Sale -105,560 $28.02 223,367
14 Sep 2026 Susan Bobulsky Chief Commercial Officer of MRD Automatic Disposition -1,195 $27.00 395,794

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 11,478,831 7.2% 6.1
15 Oct 2026 11,991,988 7.5% 5.0
30 Sep 2026 11,843,887 7.4% 4.4
15 Sep 2026 13,489,581 8.5% 7.9
31 Aug 2026 11,712,796 7.3% 6.4
14 Aug 2026 13,323,767 8.3% 5.7

Discussion

No comments yet — be the first to weigh in on ADPT.

Sign in to join the discussion.

Scroll to Top